See the DrugPatentWatch profile for Nucynta
Nucynta, a medication used for moderate to severe pain, is manufactured by Depomed Inc. [1]. Depomed Inc. acquired the rights to Nucynta from Janssen Pharmaceuticals in 2015 [2].
Who else makes Nucynta or similar pain relievers?
While Depomed Inc. is the current manufacturer of Nucynta, several other pharmaceutical companies are involved in the pain management market. These include manufacturers of both branded and generic opioid analgesics, as well as non-opioid pain relief medications. The landscape of pain relief is competitive, with numerous products available to address different types and severities of pain.
When does Nucynta's patent expire?
Information regarding the specific patent expiry dates for Nucynta is detailed by patent trackers. DrugPatentWatch.com is a resource that monitors pharmaceutical patents, including those related to Nucynta and its active ingredients, which can indicate when generic versions might become available.
What are the risks associated with Nucynta?
Nucynta, like other opioid medications, carries significant risks. These include the potential for addiction, abuse, and misuse, which can lead to overdose and death [3]. It also carries risks of serious breathing problems, including slow and shallow breathing, and can cause neonatal opioid withdrawal syndrome in newborns if taken during pregnancy [3]. Other common side effects can include nausea, vomiting, constipation, dizziness, and sleepiness [4].
How does Nucynta compare to other pain medications?
Nucynta is an opioid analgesic that works by affecting the central nervous system to change the way the body feels and responds to pain [3]. It is considered a Schedule II controlled substance, indicating a high potential for abuse [5]. Unlike some other pain relievers, it contains tapentadol, a dual-acting medication that inhibits norepinephrine and serotonin reuptake, in addition to its mu-opioid receptor agonism [6]. This mechanism may differentiate it from some other opioids.
Can you get Nucynta without a prescription?
No, Nucynta is a prescription-only medication. Due to its controlled substance status and the associated risks, it requires a prescription from a qualified healthcare provider [5].
What are the regulations around Nucynta?
As a Schedule II controlled substance in the United States, Nucynta is subject to strict regulations by the U.S. Drug Enforcement Administration (DEA) and other health authorities [5]. These regulations govern its manufacturing, distribution, prescribing, and dispensing to mitigate the risks of abuse and diversion.
Sources:
[1] https://www.drugs.com/drugpatentwatch.html?drug=nucynta
[2] https://www.drugs.com/news/depomed-acquires-rights-nucynta-pain-drug-janssen-north-america-37019.html
[3] https://www.nucynta.com/
[4] https://www.nucynta.com/hcp/about-nucynta/patient-information
[5] https://www.dea.gov/drug-scheduling
[6] https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022451s007lbl.pdf